Abstract:Background The transcription factor Spi-1 proto-oncogene (SPI1, also known as PU.1) is a key regulator of signal communication in the immune system and is essential for the development of myeloid cells and lymphocytes. However, the potential role of SPI1 in gastric cancer (GC) and the correlations between SPI1 and immune infiltration remain unclear. Methods In the present study, multiple databases including ONCOMINE, TIMER, Kaplan–Meier Plotter, and The Cancer Genome Atlas were used to explore the expression levels and prognostic value of SPI1 in GC. cBioPortal was used to explore the possible reasons for the increased expression of SPI1 in GC. The correlations between SPI1 expression and tumor-infiltrating immune cells (TICs) were analyzed using CIBERSORT and TIMER. Gene set enrichment analysis was used to determine the biological function of SPI1 in the development of GC. In addition, a risk signature based on SPI1-related immunomodulators was constructed to accurately evaluate the prognosis of patients with GC. The upregulation of SPI1 expression in GC was further confirmed through immunohistochemistry, western blotting, and real-time quantitative PCR (RT-qPCR) assay. Results The expression of SPI1 was increased significantly in GC according to multiple databases, and high expression of SPI1 was related to poor prognosis and progression of GC. The main factor influencing the high expression of SPI1 mRNA in GC may be diploidy, not DNA methylation. Moreover, immunohistochemistry, western blotting, and RT-qPCR assays also confirmed the upregulated expression of SPI1 in GC. CIBERSORT analysis revealed that SPI1 expression was correlated with seven types of TICs (naive B cells, resting memory CD4 T cells, activated memory CD4 T cells, activated natural killer cells, resting natural killer cells, M2 macrophages, and resting dendritic cells). Gene set enrichment analysis indicated that SPI1 might be related to immune activation in GC and participate in cell cycle regulation. In addition, based on SPI1-related immunomodulators, we developed multiple-gene risk prediction signatures and constructed a nomogram that can independently predict the clinical outcome of GC. Conclusion The results of the present study suggest that SPI1 has a critical role in determining the prognosis of GC patients and may be a potential immunotherapeutic target.

SP1 Mediated PIK3CB Upregulation Promotes Gastric Carcinogenesis

JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development

CRISPLD1 Promotes Gastric Cancer Progression by Regulating the Ca2+/PI3K-AKT Signaling Pathway

Overexpressed MAGP1 is Associated with a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer

Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library

Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells

Expression, Characteristics, and Clinical Target Prediction of PIK3C3/ vps34 in Gastric Cancer

Chromatin Remodeling Gene AT-rich Interactive Domain-Containing Protein 1A Suppresses Gastric Cancer Cell Proliferation by Targeting PIK3CA and PDK1.

GIPC1 Promotes Tumor Growth and Migration in Gastric Cancer Via Activating PDGFR/PI3K/AKT Signaling.

Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk.

Long Noncoding RNA UCA1 Induced by SP1 Promotes Cell Proliferation Via Recruiting EZH2 and Activating AKT Pathway in Gastric Cancer.

CLIC1 Promotes the Progression of Gastric Cancer by Regulating the MAPK/AKT Pathways

SPP1 Targeted by Mir-4262 in Gastric Cancer Functions As an Enhancer of Cell Growth and Correlates with Dismal Prognosis

Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer

PIEZO1 Functions As a Potential Oncogene by Promoting Cell Proliferation and Migration in Gastric Carcinogenesis

SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases

High expression of PIK3CB is an independent prognostic predictor for gastric adenocarcinoma

Elevated PRC1 in Gastric Carcinoma Exerts Oncogenic Function and is Targeted by Piperlongumine in a P53-Dependent Manner.

The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines

PLXNC1 Enhances Carcinogenesis Through Transcriptional Activation of IL6ST in Gastric Cancer

Pgc-1 Alpha/Snai1 Axis Regulates Tumor Growth And Metastasis By Targeting Mir-128b In Gastric Cancer